03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Zomax IV* : | |
Type | Medicine Non Marketed |
Originator | Zithromax IV* |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Hikma Italia SPA |
Manufacturing Type | G |
Origin | Italy |
ATC | J01FA10 |
Zomax IV* :
Zomax IV* :
Zomax IV* :
Zomax IV* :
Zomax IV* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Zomax IV* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Ageusia (Taste loss) | Not known |
Aggressive reaction | Not known |
Agitation | Not known |
Alkaline phosphatase serum increased | Not known |
ALT increased | Not known |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Common |
Anosmia (smell loss) | Not known |
Anxiety | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
AST increased | Not known |
Asthenia | Not known |
Blood bilirubin increased | Not known |
Bronchospasm | Uncommon |
Constipation | Not known |
Convulsion | Not known |
Creatinine increased | Not known |
Deafness | Not known |
Diarrhoea (Diarrhea) | Common |
Dizziness | Not known |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Uncommon |
Erythema multiforme | Not known |
Fatigue | Not known |
Flatulence | Uncommon |
Gastritis | Uncommon |
Headache | Uncommon |
Hearing impaired | Not known |
Hearing loss | Not known |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatic necrosis | Not known |
Hepatitis | Not known |
Hyperactivity (Increased activity) | Not known |
Hypotension | Not known |
Injection site inflammation | Common |
Injection site pain | Common |
Interstitial nephritis | Not known |
Jaundice cholestatic (Cholestatic icterus) | Not known |
LDL Increased | Not known |
Leucopenia (Leukopenia) | Not known |
Liver function test abnormal | Not known |
Loose stools (Soft stools) | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Malaise | Not known |
Mucositis | Uncommon |
Nausea | Very Common |
Nervousness | Not known |
Neutropenia | Not known |
Oedema | Not known |
Oral candidiasis | Not known |
Oral moniliasis | Uncommon |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Not known |
Parosmia | Not known |
Platelet count decreased (Thrombocyte count decreased) | Not known |
Pruritus | Common |
Pseudomembranous colitis | Not known |
Pyloric stenosis | Not known |
QT interval prolonged (QT prolongation) | Not known |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Skin rash | Common |
Somnolence | Uncommon |
Stevens-Johnson syndrome | Not known |
Syncope | Not known |
Thrombocytopenia (Thrombopenia) | Not known |
Tinnitus | Not known |
Tongue discolouration | Not known |
Torsade de pointes | Not known |
Urticaria | Not known |
Vaginitis | Common |
Ventricular tachycardia | Not known |
Vertigo | Not known |
Vomiting | Common |
Zomax IV* :
NB : Products With Same Indication |
Different Units By MoH Code
Zomax IV* MoH 5287 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | Box of 1 |
Strength | 500mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 24665/07 |
Submission date | 01/01/2007 |
Registration Year | 2009 |
Archived Date | 2017 |
Price Comparison
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 8.5 JOD | ( 1,064,378.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 8,5 JOD | ( 1,001,768.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File